India arrests two in week of counterfeit drug raids

Perhaps the FDA was watching last week as India's Central Bureau of Investigation arrested the heads of two drug companies for allegedly manufacturing adulterated medicines. Gurbachan Singh of J P Herbal Pharmacy and Navin Gadekar of Nalini Ayurvedic Co. have been taken into custody.

Bureau director Ashwani Kumar said the raids were conducted to check the supply and manufacturing of counterfeits, the sale of expired medicines and the movement of counterfeits through the Indian supply chain. CBI agents raided facilities from May 12 to 19, 2010, in New Delhi, Nagpur and Chennai. The agents also made 62 surprise visits to facilities. Six cases are moving forward.

Those are different matters than manufacturing violations, of course. But the FDA is currently reviewing draft guidelines to aid in selecting the cases for which it will pursue misdemeanor prosecutions of corporate officers for lingering GMP beaches.

- see the article

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.